Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Patent
1993-07-13
1995-05-23
Knode, Marian C.
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
4351733, 435238, 424529, 424530, 424531, 424532, 424533, 424534, A01N 102, C12N 1300, C12N 706
Patent
active
054181305
ABSTRACT:
A method is provided for inactivating viral and/or bacterial contamination in blood cellular matter, such as erythrocytes and platelets, or protein fractions. The cells or protein fractions are mixed with chemical sensitizers and irradiated with, for example, UV, visible, gamma or X-ray radiation. In particular, quaternary ammonium or phosphonium substituted, halo-psoralen compounds are described as being useful.
REFERENCES:
patent: 2720485 (1955-10-01), Bruekner et al.
patent: 3019168 (1962-01-01), Taylor
patent: 3333583 (1967-08-01), Bodell
patent: 3399264 (1968-08-01), Hyman
patent: 3686395 (1972-08-01), Stephan
patent: 3779706 (1973-12-01), Nablo
patent: 3788319 (1974-01-01), Gillette
patent: 3802432 (1974-04-01), Djerassi
patent: 3857393 (1974-12-01), Rose
patent: 3892236 (1975-07-01), Djerassi
patent: 3929130 (1975-12-01), Hargest et al.
patent: 3940249 (1976-02-01), McClurg
patent: 3962252 (1976-06-01), Wu
patent: 3963613 (1976-06-01), Chibata et al.
patent: 3993560 (1976-11-01), Halpern
patent: 4008136 (1977-02-01), Williams
patent: 4021551 (1977-05-01), Cullen
patent: 4039413 (1977-08-01), Kraemer et al.
patent: 4071412 (1978-01-01), Eisenberg et al.
patent: 4103685 (1978-08-01), Lupien et al.
patent: 4124598 (1978-11-01), Hearst et al.
patent: 4150134 (1979-04-01), Schulenberg
patent: 4160644 (1979-07-01), Ryan
patent: 4196281 (1980-04-01), Hearst et al.
patent: 4197088 (1980-04-01), Meserol et al.
patent: 4216770 (1980-08-01), Cullis et al.
patent: 4235887 (1980-11-01), Voorhees et al.
patent: 4251437 (1981-02-01), Rasmussen et al.
patent: 4268279 (1981-05-01), Shindo et al.
patent: 4291034 (1981-09-01), Werbel
patent: 4308249 (1981-12-01), Frank et al.
patent: 4314061 (1982-02-01), Murdock
patent: 4321918 (1982-03-01), Clark, II
patent: 4321919 (1982-03-01), Edelsen
patent: 4325715 (1982-04-01), Bowman
patent: 4329986 (1982-05-01), Babb
patent: 4350156 (1982-09-01), Malchesky et al.
patent: 4370264 (1983-01-01), Kotitschke et al.
patent: 4398031 (1983-08-01), Bender et al.
patent: 4398906 (1983-08-01), Edelson
patent: 4401647 (1983-08-01), Krohn et al.
patent: 4402318 (1983-09-01), Swartz
patent: 4409105 (1983-11-01), Hayashi et al.
patent: 4411518 (1983-10-01), Meserol et al.
patent: 4428744 (1984-01-01), Edelson
patent: 4436821 (1984-03-01), Ryan
patent: 4464166 (1984-08-01), Edelson
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4479798 (1984-10-01), Parks
patent: 4503039 (1985-03-01), Kotitschke et al.
patent: 4540573 (1985-09-01), Neurath et al.
patent: 4545987 (1985-10-01), Giles et al.
patent: 4568542 (1986-02-01), Kronenberg
patent: 4595653 (1986-06-01), Kronenberg
patent: 4613322 (1986-09-01), Edelson
patent: 4613501 (1986-09-01), Horowitz et al.
patent: 4620908 (1986-11-01), Van Duzer
patent: 4683120 (1987-07-01), Meserol et al.
patent: 4684521 (1987-08-01), Edelson
patent: 4693981 (1987-09-01), Wiesehahn et al.
patent: 4727027 (1988-02-01), Wiesehahn et al.
patent: 4729959 (1988-03-01), Ryan
patent: 4748120 (1988-05-01), Wiesehahn
patent: 4755684 (1988-07-01), Leiner et al.
patent: 4764369 (1988-08-01), Neunath et al.
patent: 4788139 (1988-11-01), Ryan
patent: 4791062 (1988-12-01), Wiesehahn et al.
patent: 4820805 (1989-04-01), Neurath et al.
patent: 4837160 (1989-06-01), Meserol et al.
patent: 4841023 (1989-06-01), Horowitz
patent: 4866073 (1989-09-01), Bair
patent: 4866282 (1989-09-01), Miripol et al.
patent: 4870018 (1989-09-01), Lehmann
patent: 4874690 (1989-10-01), Goodrich et al.
patent: 4877866 (1989-10-01), Rudnick et al.
patent: 4878891 (1989-11-01), Judy et al.
patent: 4891319 (1990-01-01), Roser
patent: 4898891 (1990-02-01), Lavie et al.
patent: 4909940 (1990-03-01), Horowitz et al.
patent: 4927502 (1990-05-01), Reading et al.
patent: 4946648 (1990-08-01), Dictelmuller et al.
patent: 4950665 (1990-08-01), Floyd
patent: 4952812 (1990-08-01), Miripol et al.
patent: 4971760 (1990-11-01), Rubenstein
patent: 4973327 (1990-11-01), Goodrich et al.
patent: 4992272 (1991-02-01), Bass et al.
patent: 5000951 (1991-03-01), Bass et al.
patent: 5004355 (1991-04-01), Ryan
patent: 5008201 (1991-04-01), Ryan
patent: 5011695 (1991-04-01), Dichtelmuller et al.
patent: 5026566 (1991-06-01), Roser
patent: 5026840 (1991-06-01), Dahagrupta et al.
patent: 5030200 (1991-07-01), Judy et al.
patent: 5049589 (1991-09-01), Lavie et al.
patent: 5053121 (1991-10-01), Schoendorfer et al.
patent: 5053423 (1991-10-01), Liu
patent: 5106619 (1992-04-01), Wiesehahn et al.
patent: 5120412 (1992-06-01), Mazur et al.
patent: 5120649 (1992-06-01), Horowitz et al.
patent: 5149653 (1992-09-01), Roser
patent: 5176921 (1993-01-01), Wiesenhahn et al.
patent: 5182111 (1993-01-01), Aebischer et al.
patent: 5185371 (1993-02-01), Rubenstein
patent: 5186945 (1993-02-01), Shanbrom
patent: 5216176 (1993-06-01), Heindel et al.
patent: 5263925 (1993-11-01), Gilmore, Jr. et al.
patent: 5288605 (1994-02-01), Lin et al.
patent: 5292414 (1994-03-01), Sessler et al.
patent: 5356929 (1994-10-01), Heindel et al.
CCBC Newsletter Dec. 21/28 1990.
Lown et al., 9. Med. Chem. 32:2368-2375 (1989).
Debart et al, 9. Med. Chem. 32:1074-1083 (1989).
Polak 9 et al, Pharm. Delt, Epistom Ekoosis 1:27-33 (1971).
Mahnel H. et al, Zbl. Baki., I. Abt. Orig. B 170:57-70 (1980).
Alter, H. J. et al, The Lancet Dec. 24/31:1446-1450 (1988).
Hansen, J. B. et al, J. Med Chem 28:1001-1010 (1985).
Gibbs, Jr. C. et al, Proc. Natl Acad Sci USA 75:6268-6270 (1978).
Potapenko, A. Y., et al., "8-Methoxypsoralen-sensitized Photooxidation of Tocopherols", Photochem. Photobiophy., V. 5, pp. 113-117 (1983).
Artuc, M. et al, "Reversible Binding of 5- and 8- Methoxy-Psoralen to Human Serum Proteins (Albumin) and to Epidermis In Vitro", British J. Dermatol., V. 101, 669-677 (1979).
Ashwood-Smith, M. J. et al., "5-Methoxypsoralen, an Ingredient in Several Suntan Preparations, has Lethal, Mutagenic and Clastogenic Properties", Nature V. 285, pp. 407-409, (1980).
Bahnemann, "Inactivation of Viruses in Serum with Binary Ethyleneimine," J. Clin. Microbiol., V. 3, No. 2, pp. 209-210, (1976).
Chun, C. C. Y., "Kinetics of Psoralen Photoreaction with Deoxyribonucleic Acid", UMI Dissertation Services 1982.
Chabner et al, Cancer: Principles and Practice of Oncology, Chapter 14, pp. 311-312 (1985) V. DeVita editor.
Khan et al., J. Virology 21: 16-23 (1977).
Kalab D., Experentia 23: 181-182 (1967). Goodrich, et al., (1994) Proc. Natl. Acad. Sci. USA 91:5552-5556, Selective Inactivation of Viruses in the Presence of Human Platelets: UV Sensitization with Psoralen Derivatives.
Goodrich, et al., (1994) Proc. Natl. Acad. Sci. USA 91:5552-5556, Selective Inactivation of Viruses in the Presence of Human Platelets: UV Sensitization with Psoralen Derivatives.
Gasparro, F. P., Psoralen DNA Photobiology pp. 37, 39-46 CRC Press, Inc. (1988).
Cimino, G. D., et al., "Psoralens as Photoactive Probes of Nucleic Acid Structure and Function: Organic Chemistry, Photochemistry, and Biochemistry", Ann. Rev. Biochem., V. 54, pp. 1151-1193 (1985).
Colombo, G. et al., "Photosensitization of Mammalian Cells and of Animal Viruses by Furocoumarins", Progr. Biochem. Pharmacol., V. 1, pp. 392-399 (1965).
Dodd, R. Y., et al., "Inactivation of Viruses in Platelet Suspensions that Retain Their in Vitro Characteristics: Comparison of Psoralen-Ultraviolet A and Merocyanine 540-Visible Light Methods", Transfusion, V. 31, No. 6, pp. 483-490 (1991).
Edelson, R. L., "Light-Activated Drugs", Scientific American, pp. 68-75 (Aug. 1988).
Edelson, R., et al., "Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy", New England J. of Med., V. 316, No. 6, pp. 297-303 (1987).
El-Hefnawi, H., et al., "Electrophoretic Studies of Serum Proteins in Vitiligenous Patients Treated with Oral Psoralens and Ultra-Violet Irradiation", J. Invest. Dermatol., V. 40, No. 2, pp. 111-119 (1963).
Farid, S., et al., "Photochemical and -Biological Reactions of the Furocoumarins", Radiation Research, pp. 869-886 (1966).
Frederiksen, S. et al., "Binding of 4'-Aminomethyl 4,5'8-Trimethyl Psoralen to DNA, RNA and Protein in HeLa Cells and Drosophila Cells", Biochimica et Biophysica Acta, V. 563,
Goodrich, Jr. Raymond P.
Platz Matthew S.
Yerram Nagendar
Cryopharm Corporation
Knode Marian C.
Saucier Sandra
LandOfFree
Method of inactivation of viral and bacterial blood contaminants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inactivation of viral and bacterial blood contaminants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inactivation of viral and bacterial blood contaminants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2139955